Effect of PCSO-524 on OA Biomarkers and Weight-Bearing Properties in Canine Shoulder and Coxofemeral Osteoarthritis June 26, 2024June 26, 2024 | Vetz Petz Antinol
Clinical studies basics – What are clinical trials, why do we do them, and how do I know if they’re good? June 25, 2024June 26, 2024 | Vetz Petz Antinol
Clinical study comparing Antinol+® and Antinol® with Rimadyl® and glucosamine and chondroitin for the treatment of dogs with osteoarthritis March 27, 2024June 26, 2024 | Vetz Petz Antinol
The effectiveness of marine-based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis March 27, 2024June 26, 2024 | Vetz Petz Antinol
Effectiveness of disease modifying osteoarthritis agents and carprofen for treatment of canine osteoarthritis March 27, 2024June 26, 2024 | Vetz Petz Antinol
